| (Values in U.S. Thousands) | Jun, 2018 | Mar, 2018 | Dec, 2017 | Sep, 2017 | Jun, 2017 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 0 |
| Net Income Growth | unch | unch | unch | unch | unch |
Premd Inc (PREMF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
PreMD Inc. is a predictive medicine company focused on developing rapid, non-invasive tests for the early detection of life-threatening diseases. Its cardiovascular products include PREVU(x) POC and PREVU(x) LT. The Company's cancer tests include ColorectAlert(TM), LungAlert(TM) and a breast cancer test. PreMD Inc., was formerly known as IMI International Medical Innovations, Inc., and is headquartered in Toronto, Canada.
Fiscal Year End Date: 12/31